Intrathecal pumps are devices that are used to deliver precise medication dosages into the human body, notably within the spinal cord. Intrathecal pumps have become more popular in recent years as the precision of these devices has improved.
With no/minimal adverse effects, intrathecal pumps are often utilized in the treatment of chronic pain sufferers across the world. Intrathecal pump demand has been bolstered by economic considerations such as the U.S. health insurance policy. Aside from that, the intrathecal pumps market is being driven by the advancement in technology of these devices, as well as the increasing practicality and flexibility of the current diagnostic procedures. Because drugs like Baclofen and Trihexy-phenidyl, which are used to treat neurodegeneration with brain iron accumulation and dystonia, are not available in pill form, the demand for technically advanced intrathecal pumps that can administer multiple medications through a single infusion pump has risen in recent years.
Among all geographical segments, Asia-Pacific has the fastest-growing intrathecal pump market. Due to the high frequency of cancer in emerging nations such as India and China, the Asia-Pacific market is anticipated to expand by double digits in the next years. Furthermore, rising disposable income, improved healthcare, infrastructure, and favorable government regulation have all aided the adoption of sophisticated diagnostic equipment like intrathecal pumps. The U.S. and Canada are North America's two major intrathecal pump markets. Other nations that have played a major influence in the growth of the European Intrathecal Pumps market are Germany, Italy, France, United Kingdom, and Spain. As a result, Japan, China, and India dominate the intrathecal pump market in the Asia Pacific.